Reported Toxicities Associated with Stereotactic Body Radiation Therapy

[1]  Andrew Jackson,et al.  Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer. , 2012, International journal of radiation oncology, biology, physics.

[2]  R. Barriger,et al.  A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. , 2009, International journal of radiation oncology, biology, physics.

[3]  C. Reddy,et al.  Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT). , 2009, International journal of radiation oncology, biology, physics.

[4]  W. Moore,et al.  Pulmonary function testing after stereotactic body radiotherapy to the lung. , 2009, International journal of radiation oncology, biology, physics.

[5]  J. Fowler,et al.  Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. , 2012, International journal of radiation oncology, biology, physics.

[6]  Suresh Senan,et al.  Incidence and Risk Factors for Chest Wall Toxicity After Risk-Adapted Stereotactic Radiotherapy for Early-Stage Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[7]  E. Kasper,et al.  Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases. , 2011, International journal of radiation oncology, biology, physics.

[8]  Cynthia S. Johnson,et al.  Stereotactic body radiotherapy for primary hepatocellular carcinoma. , 2011, International journal of radiation oncology, biology, physics.

[9]  J. Mechalakos,et al.  Temporary Organ Displacement for Stereotactic Body Radiation Therapy , 2011 .

[10]  N. Mayr,et al.  Stereotactic body radiation therapy for prostate cancer. , 2011, Future oncology.

[11]  Joe Y. Chang,et al.  Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy. , 2011, International journal of radiation oncology, biology, physics.

[12]  Zhibin Huang,et al.  Emerging applications of stereotactic body radiation therapy for head and neck cancer , 2011, Expert review of anticancer therapy.

[13]  F. Zorlu,et al.  Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. , 2011, International journal of radiation oncology, biology, physics.

[14]  A. Garg,et al.  Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy , 2011, Cancer.

[15]  Peter A S Johnstone,et al.  Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver. , 2011, International journal of radiation oncology, biology, physics.

[16]  Zhibin Huang,et al.  Emerging application of stereotactic body radiation therapy for gynecologic malignancies , 2011, Expert review of anticancer therapy.

[17]  Y. Lotan,et al.  Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  D. Heron,et al.  Concurrent Cetuximab With Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck: A Single Institution Matched Case-Control Study , 2010, American journal of clinical oncology.

[19]  H. Yamazaki,et al.  Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. , 2011, Journal of radiation research.

[20]  A. Koong,et al.  A dosimetric model of duodenal toxicity after stereotactic body radiotherapy for pancreatic cancer. , 2010, International journal of radiation oncology, biology, physics.

[21]  A. Noone,et al.  Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. , 2010, International journal of radiation oncology, biology, physics.

[22]  James Ze Wang,et al.  Stereotactic body radiation therapy: a novel treatment modality , 2010, Nature Reviews Clinical Oncology.

[23]  E. Kunieda,et al.  Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors. , 2010, International journal of radiation oncology, biology, physics.

[24]  Lijun Ma,et al.  Spinal cord tolerance for stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[25]  K. Ohtomo,et al.  Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy , 2010, Radiation oncology.

[26]  Jian Z. Wang,et al.  Stereotactic body radiation therapy for hepatocellular carcinoma. , 2010, Discovery medicine.

[27]  Umberto Ricardi,et al.  Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial. , 2010, Lung cancer.

[28]  Jian Z. Wang,et al.  Stereotactic body radiation therapy for spinal metastases. , 2010, Discovery medicine.

[29]  S. Perkins,et al.  Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma , 2010, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[30]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[31]  Ke Sheng,et al.  Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[32]  Hong Ye,et al.  Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  T. Krieger,et al.  Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  K. Rosenzweig,et al.  Low rate of thoracic toxicity in palliative paraspinal single-fraction stereotactic body radiation therapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  Peter A S Johnstone,et al.  Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[36]  M. Bilsky,et al.  Risk of fracture after single fraction image-guided intensity-modulated radiation therapy to spinal metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  S. Waggoner,et al.  Stereotactic Body Radiosurgery for Pelvic Relapse of Gynecologic Malignancies , 2009, Technology in cancer research & treatment.

[38]  Seong Soo Shin,et al.  Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. , 2009, Lung cancer.

[39]  R. Timmerman,et al.  Stereotactic body radiation therapy for early stage non-small cell lung cancer (Expert Review of Anticancer Therapy (2008) 8, 1 (87-98)) , 2009 .

[40]  A. Bezjak,et al.  Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer. , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[41]  S. Ryu,et al.  Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. , 2009, International journal of radiation oncology, biology, physics.

[42]  Jan Nyman,et al.  Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Lijun Ma,et al.  Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. , 2009, International journal of radiation oncology, biology, physics.

[44]  C. Reddy,et al.  Comprehensive Analysis of Pulmonary Function Test (PFT) Changes After Stereotactic Body Radiotherapy (SBRT) for Stage I Lung Cancer in Medically Inoperable Patients , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[45]  Jan Nyman,et al.  Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  Shao-xiong Wu,et al.  Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis , 2009, Head & neck oncology.

[47]  Jian Z. Wang,et al.  Stereotactic body radiation therapy for oligometastases , 2009, Expert Review of Anticancer Therapy.

[48]  G. Lockwood,et al.  Phase I study of individualized stereotactic body radiotherapy of liver metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  L. Gaspar,et al.  Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  P. Gerszten,et al.  DELAYED RADIATION‐INDUCED MYELOPATHY AFTER SPINAL RADIOSURGERY , 2009, Neurosurgery.

[51]  Kenneth E Rosenzweig,et al.  Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? , 2008, International journal of radiation oncology, biology, physics.

[52]  Joe Y. Chang,et al.  Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[53]  T. Desser,et al.  Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. , 2008, International journal of radiation oncology, biology, physics.

[54]  B. Wessels,et al.  Cyberknife Radiosurgery for Squamous Cell Carcinoma of Vulva after Prior Pelvic Radiation Therapy , 2008, Technology in cancer research & treatment.

[55]  C. Yiannoutsos,et al.  Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.

[56]  Jan Nyman,et al.  Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[57]  D. Larson,et al.  Stereotactic body radiosurgery for spinal metastases: a critical review. , 2008, International journal of radiation oncology, biology, physics.

[58]  Y. Yamada,et al.  High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. , 2008, International journal of radiation oncology, biology, physics.

[59]  P. Gerszten,et al.  RADIOSURGERY FOR BENIGN INTRADURAL SPINAL TUMORS , 2008, Neurosurgery.

[60]  Maria Hawkins,et al.  Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[61]  R. Timmerman,et al.  Stereotactic body radiation therapy for early-stage non-small-cell lung cancer , 2008, Expert review of anticancer therapy.

[62]  J. Sham,et al.  Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma. , 2007, International journal of radiation oncology, biology, physics.

[63]  K. Ohtomo,et al.  Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumors , 2007, Radiation oncology.

[64]  Steven D Chang,et al.  Image-guided robotic radiosurgery for spinal metastases. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[65]  J. Rock,et al.  Partial volume tolerance of the spinal cord and complications of single‐dose radiosurgery , 2007, Cancer.

[66]  Lech Papiez,et al.  Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  Steven D Chang,et al.  CyberKnife Radiosurgery for Benign Intradural Extramedullary Spinal Tumors , 2006, Neurosurgery.

[68]  U. Haedinger,et al.  Stereotactic radiotherapy of primary liver cancer and hepatic metastases , 2006, Acta oncologica.

[69]  B. Salter,et al.  Stereotactic body radiation therapy for centrally located lung lesions , 2006, Acta oncologica.

[70]  J. Petersen,et al.  Phase II study on stereotactic body radiotherapy of colorectal metastases , 2006, Acta oncologica.

[71]  Peter C Levendag,et al.  Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study , 2006, Acta oncologica.

[72]  Masahiro Hiraoka,et al.  Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.

[73]  Lech Papiez,et al.  Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. , 2005, International journal of radiation oncology, biology, physics.

[74]  R. Timmerman,et al.  Stereotactic body radiation therapy. , 2004, Current problems in cancer.

[75]  H. von der Maase,et al.  Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[76]  J. Itami,et al.  Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors. , 2004, Chest.

[77]  G. van Kaick,et al.  Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. , 2003, International journal of radiation oncology, biology, physics.

[78]  J. Sham,et al.  Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications. , 2003, International journal of radiation oncology, biology, physics.

[79]  K. Wei,et al.  Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma , 2002, Head & neck.

[80]  J. Sham,et al.  Salvage treatment for persistent and recurrent T1–2 nasopharyngeal carcinoma by stereotactic radiosurgery , 2001, Head & neck.

[81]  F. Lohr,et al.  Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[82]  M. Hasegawa,et al.  Stereotactic radiotherapy for locally recurrent nasopharyngeal carcinoma , 1999, The Laryngoscope.

[83]  T. Taguchi,et al.  [Phase I study]. , 1995, Gan to kagaku ryoho. Cancer & chemotherapy.